AI assistant
Sending…
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2022
Dec 30, 2022
31542_dirs_2022-12-30_be78ecf7-0cd0-4983-9bf2-b57a9d2c0ec1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2022-12-28
Reporting Person: MCENANY PATRICK J (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-28 | Common stock, par value $0.001 per share | G | 10000 | — | Disposed | 3911307 | Direct |
| 2022-12-29 | Common stock, par value $0.001 per share | G | 10000 | — | Disposed | 3901307 | Direct |
Footnotes
F1: These transactions involved bona-fide gifts to family members of the Reporting Person. The recipients of the gifts do not share the Reporting Person's household and Reporting Person retains no control over the shares gifted.
More from CATALYST PHARMACEUTICALS, INC.
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 19
Regulatory Filings
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2025
Dec 30